Insiders · INO

Peter Kies

CFO at Inovio Pharmaceuticals, Inc. (INO)

Peter Kies has filed 19 insider reports with the SEC since February 2021, as CFO at Inovio Pharmaceuticals, Inc. (INO). Peter Kies made no open-market purchases or sales in the last 12 months. The latest filing, on May 21, 2026, reports grant or award, shares withheld for taxes or exercise price and exercise or conversion of a derivative at Inovio Pharmaceuticals, Inc. (INO).

Filings
19
Companies
1
Bought on market
None
Sold on market
$423K

Companies where Peter Kies is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Inovio Pharmaceuticals, Inc. logo
INO
Inovio Pharmaceuticals, Inc.
CFO42,854$423K$1.69May 21, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Peter Kies with

Other insiders at the same companies

Questions about Peter Kies

What is Peter Kies's role at Inovio Pharmaceuticals, Inc.?
Peter Kies reports to the SEC as CFO at Inovio Pharmaceuticals, Inc. (INO), according to the latest filing on May 21, 2026.
How many shares does Peter Kies own?
After the latest filing that states it, Peter Kies directly owned 42,854 shares of Inovio Pharmaceuticals, Inc. (INO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Peter Kies bought or sold stock recently?
The most recent open-market sale was on June 9, 2021: sold 33,750 shares of Inovio Pharmaceuticals, Inc. (INO) for $338K at an average of $10.01.
How do I get alerts when Peter Kies files?
Follow Peter Kies on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Peter Kies (SEC CIK 0001259780). Totals count each trade once, skipping amendments whose original is on file, from Feb 27, 2021 on. View on SEC EDGAR